Cancer Immunotherapy Research
Programming cells help to fight a brain tumor
Glioblastoma is the most common and aggressive brain tumor, with patients surviving less than two years after diagnosis.
Glioblastoma is the most common and aggressive brain tumor, with patients surviving less than two years after diagnosis.